Paper28677828
Vortioxetine for depression in adults.
Koesters M and 4 others. Cochrane Database Syst Rev, 2017. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Vortioxetine for depression in adults. Papers, record 28677828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28677828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Major Depressive Disorder | Major topic |
| Piperazines | Major topic |
| Sulfides | Major topic |
| Adult | |
| Duloxetine Hydrochloride | |
| Humans | |
| Patient Dropouts | |
| Placebos | |
| Randomized Controlled Trials as Topic | |
| Remission Induction | |
| Serotonin and Noradrenaline Reuptake Inhibitors | |
| Venlafaxine Hydrochloride | |
| Vortioxetine |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05866575 | Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 30264702 | Network meta-analysis of antidepressants. | https://conductscience.org/library/papers/30264702 |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26122791 | Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine. | CNS Spectr | 2015 | https://conductscience.org/library/papers/26122791 | PubMed |
| 2 | 24871704 | The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis. | Psychopharmacology (Berl) | 2015 | https://conductscience.org/library/papers/24871704 | PubMed |
| 3 | 24464277 | Converting an odds ratio to a range of plausible relative risks for better communication of research findings. | BMJ | 2014 | https://conductscience.org/library/papers/24464277 | PubMed |
| 4 | 23245607 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. | Lancet | 2012 | https://conductscience.org/library/papers/23245607 | PubMed |
| 5 | 22214892 | Out of sight but not out of mind: how to search for unpublished clinical trial evidence. | BMJ | 2012 | https://conductscience.org/library/papers/22214892 | PubMed |
| 6 | 22495621 | A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder. | J Psychopharmacol | 2012 | https://conductscience.org/library/papers/22495621 | PubMed |
| 7 | 22147715 | Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. | Ann Intern Med | 2011 | https://conductscience.org/library/papers/22147715 | PubMed |
| 8 | 21767441 | A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. | Int J Neuropsychopharmacol | 2012 | https://conductscience.org/library/papers/21767441 | PubMed |
| 9 | 15602117 | Imputing response rates from means and standard deviations in meta-analyses. | Int Clin Psychopharmacol | 2005 | https://conductscience.org/library/papers/15602117 | PubMed |
| 10 | 24059250 | Assessing and presenting summaries of evidence in Cochrane Reviews. | Syst Rev | 2013 | https://conductscience.org/library/papers/24059250 | PubMed |
| 11 | 18303940 | Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. | PLoS Med | 2008 | https://conductscience.org/library/papers/18303940 | PubMed |
| 12 | 9522799 | Interpreting treatment effects in randomised trials. | BMJ | 1998 | https://conductscience.org/library/papers/9522799 | PubMed |
| 13 | 26035185 | A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder. | J Clin Psychiatry | 2015 | https://conductscience.org/library/papers/26035185 | PubMed |
| 14 | 23857675 | Preliminary study of patterns of medication use for depression treatment in China. | Asia Pac Psychiatry | 2013 | https://conductscience.org/library/papers/23857675 | PubMed |
| 15 | 20831742 | A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. | Acta Psychiatr Scand | 2011 | https://conductscience.org/library/papers/20831742 | PubMed |
| 16 | 24787143 | A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. | Int J Neuropsychopharmacol | 2014 | https://conductscience.org/library/papers/24787143 | PubMed |
| 17 | 11914297 | Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. | Int J Epidemiol | 2002 | https://conductscience.org/library/papers/11914297 | PubMed |
| 18 | 5009428 | Diagnostic criteria for use in psychiatric research. | Arch Gen Psychiatry | 1972 | https://conductscience.org/library/papers/5009428 | PubMed |
| 19 | 23357658 | What does the HAMD mean? | J Affect Disord | 2013 | https://conductscience.org/library/papers/23357658 | PubMed |
| 20 | 27013879 | The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials. | Neuropsychiatr Dis Treat | 2016 | https://conductscience.org/library/papers/27013879 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39649121 | Recent Advances in the Psychopharmacology of Major Depressive Disorder. | BJPsych Adv | 2023 | https://conductscience.org/library/papers/39649121 | PubMed |
| 39487479 | Effectiveness of 8-week TReatment with vortioxetine on depressive symptoms in major depressive disorder patients with comorbid generalized anxiety disorder in UAE (TRUE). | Ann Gen Psychiatry | 2024 | https://conductscience.org/library/papers/39487479 | PubMed |
| 38869643 | Depression and anxiety in multiple sclerosis. Review of a fatal combination. | J Neural Transm (Vienna) | 2024 | https://conductscience.org/library/papers/38869643 | PubMed |
| 37922101 | SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC? | Curr Top Behav Neurosci | 2024 | https://conductscience.org/library/papers/37922101 | PubMed |
| 37626556 | Depression and Pseudodementia: Decoding the Intricate Bonds in an Italian Outpatient Setting. | Brain Sci | 2023 | https://conductscience.org/library/papers/37626556 | PubMed |
| 37513187 | Coriandrum sativum and Its Utility in Psychiatric Disorders. | Molecules | 2023 | https://conductscience.org/library/papers/37513187 | PubMed |
| 37046135 | Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues and Potential Solutions. | Pharmaceut Med | 2023 | https://conductscience.org/library/papers/37046135 | PubMed |
| 36387336 | Real-world pharmacological treatment of patients with postpartum depression in China from 2016 to 2020: A cross-sectional analysis. | Saudi Pharm J | 2022 | https://conductscience.org/library/papers/36387336 | PubMed |
| 36358393 | Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson's Disease Patients with Major Depression: An Open-Label Prospective Study. | Brain Sci | 2022 | https://conductscience.org/library/papers/36358393 | PubMed |
| 35955946 | The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955946 | PubMed |
| 35815048 | Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults. | Front Psychiatry | 2022 | https://conductscience.org/library/papers/35815048 | PubMed |
| 35740340 | Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant. | Biomedicines | 2022 | https://conductscience.org/library/papers/35740340 | PubMed |
| 35272591 | Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma. | Curr Neuropharmacol | 2022 | https://conductscience.org/library/papers/35272591 | PubMed |
| 35020178 | Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports. | Drug Saf | 2022 | https://conductscience.org/library/papers/35020178 | PubMed |
| 35015359 | The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. | World Psychiatry | 2022 | https://conductscience.org/library/papers/35015359 | PubMed |
| 34888167 | G-protein coupled receptors and synaptic plasticity in sleep deprivation. | World J Psychiatry | 2021 | https://conductscience.org/library/papers/34888167 | PubMed |
| 34681209 | Rediscovering Psilocybin as an Antidepressive Treatment Strategy. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34681209 | PubMed |
| 34252320 | Key considerations in the pharmacological management of treatment-resistant depression. | Expert Opin Pharmacother | 2021 | https://conductscience.org/library/papers/34252320 | PubMed |
| 34211395 | Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34211395 | PubMed |
| 33971984 | Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs. | Res Integr Peer Rev | 2021 | https://conductscience.org/library/papers/33971984 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC6A4 | 6532 | PubTator's text mining | https://conductscience.org/library/genes/6532 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28677828
GET https://conductscience.org/api/papers/v1/28677828/references?page=2